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FIGURE 1. A, Opening the mitral valve anterior leaflet. Curved robotic scissors were used to incise the anterior leaflet, proceeding counterclockwise in a
radial fashion from the right fibrous trigone to the left fibrous trigone. B, Exposure of the interventricular septum and aortic valve through the mobilized
mitral valve anterior leaflet. C, Resection of the previously ablated fibrotic interventricular septum. The rectangular resected tissue was extended clockwise
from near the left fibrous trigone to the nadir of the right coronary cusp.
Surgical TechniquesDISCUSSION
The Morrow procedure uses a midline sternotomy, with
the left ventricle and septum accessed by the aortic valve
through a vertical aortotomy.4 The potential limitations of
the procedure include small, but persistent, risks of an aor-
totomy (eg, postoperative bleeding, aortic dissection), diffi-
culties with visualizing the surgical anatomy, and the risk of
aortic valve damage (approximately 5% rate of moderate
aortic regurgitation postoperatively5).
A robotic approach using the left atrium and across the
mitral valve is an alternative and more direct route to the
ventricular septum that can circumvent the limitations of
the standard transaortic approach. The required robotic
manipulation of the mitral valve for left ventricular septum
access seems less risky than the transaortic route across the
often friable aortic valve for provoking valvular damage.
Although additional studies are needed to evaluate the
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procedure.
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center study. Circulation. 2013;127:1184-91.Modified surgical approach to symptomatic hypertrophic
cardiomyopathy with abnormal papillary muscle morphology:
Septal myectomy plus papillary muscle repositioningMarianna Redaelli, MD, Camillo Luca Poloni, MD, Samuele Bichi, MD, and Giampiero Esposito, MD,
Bergamo, ItalyHypertrophic obstructive cardiomyopathy (HOCM) is
considered a primary disease of cardiac muscle characte-
rized by a diverse morphologic and clinical spectrum.1,2
The physiopathology of hypertrophic cardiomyopathy
has been clarified by advanced echocardiographic and
magnetic resonance imaging technologies (cardiac
magnetic resonance imaging). With these advances,
surgical management has also evolved, because the role
of the mitral valve and subvalvular structures in causingdiovascular Surgery c Volume 147, Number 5 1709
TABLE 1. Clinical and morphologic features for 15 patients with
HOCM due to anomalous papillary muscle insertion
Parameter Value
Median age (y) 61
NYHA functional class
Preoperative
Class III 9
Class II 6
Postoperative, class I 15
Gender
Male 5
Female 10
Basal LVOTG (mm Hg)
Preoperative
Minimum 40
Peak 63
Postoperative
Range 0-18
Median 10
SAM
Preoperative 15
Postoperative 0
Mitral regurgitation
Preoperative
Moderate 7
Mild 8
Postoperative
No gradient 11
Mild 4
Preoperative LV wall thickness, anterior septum (mm) 23
Postoperative LV wall thickness, anterior septum (mm) 12-15
HOCM, Hypertrophic obstructive cardiomyopathy; NYHA, New York Heart
Association; LVOTG, left ventricular outflow tract gradient; SAM, systolic anterior
motion; LV, left ventricular.
FIGURE 1. Computed tomography scans showing (A) an obstructed
outflow tract (preoperative image) and (B) a wide outflow (postoperative
image).
Surgical Techniquesobstruction has been clarified. A recent study has
demonstrated that abnormal papillary muscle morphology
was associated with dynamic left ventricular outflow tract
(LVOT) obstruction, independent of the basal septal
thickness.3
The most common cause of obstruction is contact be-
tween anterior leaflet of the mitral valve and hypertrophied
septum, commonly know as systolic anterior motion
(SAM). In a subset of patients with HOCM, LVOT
obstruction will be present in the midcavity region owing
to muscular apposition created by abnormal papillary
muscle morphology. Failure to recognize this anomaly
can have catastrophic consequences during surgery,
because the standard myotomy and myectomy will not
relieve the obstruction.4
We report the baseline characteristics and short-term out-
comes of patients with HOCM who had undergone septal
myectomy plus anterior papillary muscle repositioning.
METHODS
From January 2002 to January 2012, 98 patients with HOCM were
referred for surgical intervention for symptomatic LVOT obstruction after1710 The Journal of Thoracic and Cardiovascular Surundergoing a comprehensive clinical, electrocardiographic, and imaging
evaluation. Of these 98 patients, 15 presented with abnormal papillary
muscle morphology (Table 1). In this subgroup of HOCM, an innovative
surgical strategy was applied. The institutional review board approved
the study. The requirement for patient consent was waived.
Our alternative subvalvular surgical solution in treating complex
HOCM with SAM included extensive myectomy plus repositioning of
the anterior papillary muscle and excision of the accessory papillary
muscle and chords. This procedure was completed by implantation of a
complete semirigid ring (Memo 3D, Sorin, Saluggia, Italy).
SURGICAL TECHNIQUE
Through standard median sternotomy, the cardio-
pulmonary bypass was instituted by cannulating the
ascending aorta and right atrium with a single 2-stage
cannula. After aortic crossclamping, the crystalloid
cardioplegia solution (Custodiol HTK solution; Koehler
Chemie, Alsbach-Haenlein, Germany) was administered
in the aortic root.gery c May 2014
Surgical TechniquesThe surgical analysis was performed using a transaortic
approach. The presence of an altered morphology of the
anterior papillary muscle was then confirmed. The adequate
septal myectomy was performed as a first step by way of the
aortic valve, with rectangular muscular resection from the
nadir of the right coronary cusp into the midventricular
region to the level of the attachments of the anomalous
anterior papillary muscle (Morrow procedure).
In the presence of muscular midcavity obstruction owing
to an anomalous papillary muscle, standard myectomy was
combined with repositioning of the anterior papillary
muscle approached by way of the left atrial roof5 (second
step). This procedure was performed with an incision be-
tween the anterior and medium branch of the anterior papil-
lary muscle and union of its anterior and posterior branch
with 4-0 polypropylene suture, with interposition of a small
autologous pericardial patch to avoid muscle damage.
In the third step, a complete, semirigid ring (Memo 3D,
Sorin, Saluggia, Italy) was implanted.
RESULTS
No deaths at 30 postoperative days were observed.
Postoperative transthoracic echocardiography and cardiac
magnetic resonance imaging showed no residual gra-
dient superior to 18 mm Hg. The patients were in New
York Heart Association class I during the follow-up period.
All the patients were in sinus rhythm. After surgery,
the LVOT appeared to be widely patent throughout the
cardiac cycle. SAM was abolished without residual
mitral regurgitation in 11 patients and mild regurgitation
in 4 patients.
DISCUSSION
HOCM was considered to be a disease mostly related to
asymmetric septal hypertrophy. The main causes of
obstruction were bulging of hypertrophied interventricular
septum, indicating the presence of SAM. Other not so
rare anatomic anomalies include elongation of the anterior
leaflet, altered morphology of the anterior papillary muscle,
and presence of abnormal subvalvular segments (accessory
papillary muscles and chords).
The standard surgical technique has been the Morrow
procedure for isolated septal hypertrophy. Nevertheless,The Journal of Thoracic and Caran associated abnormal mitral valve and subvalvular
apparatus are present, this approach will not be
sufficient. For these reasons, other surgical procedures
have been developed. In the decision making, one should
consider that a significant proportion of patients will be
young and that mitral valve replacement or surgical mitral
leaflet manipulation will be undesirable. Our novel
approach was directed toward the avoidance of a mitral
valve lesion.
However, recent studies with cardiac magnetic
resonance imaging have demonstrated a high frequency of
papillary muscle abnormalities in patients with HCOM
that will frequently be missed by echocardiographic
analysis.5
With our surgical strategy, a wide outflow tract was
created by performing extended muscular resection well
beyond the site of midventricular obstruction (Figure 1).
Moreover, repositioning of the anterior papillary muscle,
followed by adjunctive implantation of a complete semi-
rigid mitral ring, has permitted the abolishment of the
SAM effect and residual mitral regurgitation.CONCLUSIONS
A tailored surgical approach in patients presenting with
HOCM, with abnormal papillary muscle morphology,
obtained optimal results in terms of gradient decrease and
the elimination of symptoms. At short-term follow-up,
all patients were asymptomatic and without need for
reoperation. However, the long-term outcomes need to be
ascertained.References
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